96424 ⎘
Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom; Pyrimidine radicals with ribosyl as the saccharide radical
THIOLATION SOLUTION
#2METHOD FOR PRODUCING 2' MODIFIED PYRIMIDINE NUCLEOSIDE
#34'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO
#4MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF
#5ALKYL HALIDE, ALKYLATING AGENT USING SAME, AND METHOD FOR PRODUCING DERIVATIVE OF NUCLEOSIDE
#6MONOMERS AND METHODS FOR SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES
#7METHOD FOR PRODUCING PRODUCTION INTERMEDIATE, PRODUCTION INTERMEDIATE THEREOF, AND METHOD FOR PRODUCING CROSSLINKED ARTIFICIAL NUCLEIC ACID INTERMEDIATE BY USING SAME
#8Oligonucleotide Terminal Phosphate Derivatives and Method of Use
#9ANTIVIRAL NUCLEOSIDE ANALOGUE, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#10Pharmaceutical Composition for Treating or Preventing Disease Caused by Reduction or Deficiency in tm5U Modification
#11NUCLEOSIDES FOR TREATING CANCER
#12N4-ISOBUTYRYLOXYCYTIDINE ANALOG SYNTHESIS AND COMPOSITION FOR TREATING VIRAL INFECTION COMPRISING ANTI-VIRAL USE THEREOF
#13OLIGONUCLEOTIDE PRODUCTION METHOD
#14STEREOSELECTIVE TECHNOLOGIES FOR CHIRAL COMPOUNDS
#15MULTI-FUNCTIONAL COMBINATION OUTLINE TOOL
#16ESTER DERIVATIVES OF N4-HYDROXYCYTIDINE AND USE THEREOF
#17ANTIVIRAL AGENT
#18SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES WITH INCREASED STABILITY
#19NOVEL UNIVERSAL ANTI-RNA VIRUS AGENTS
#20Functionalized N-acetylgalactosamine analogs
#21A PROCESS FOR THE PREPARATION OF N4-HYDROXYCYTIDINE AND ITS DERIVATIVES
#22SYNTHESIS OF MOLNUPIRAVIR BY GREEN CHEMISTRY
#23N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO
#24NUCLEOSIDE ANALOG AND USE THEREOF
#25COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THE SAME
#26COMPOSITIONS AND COMPOUNDS FOR CO-DELIVERY OF URIDINE AND KETOLEUCINE
#27PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#28ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF
#29Spin-Labeled Nucleosides and Phosphoramidites
#30SYNTHESIS OF OLIGONUCLEOTIDES AND RELATED COMPOUNDS
#31CYTOSINE-TYPE BRIDGED NUCLEOSIDE AMIDITE CRYSTALS AND METHOD FOR PRODUCING SAME
#32N-ACETYLGALACTOSAMINE (GALNAC)-DERIVED COMPOUNDS AND OLIGONUCLEOTIDES
#33NOVEL FORMS OF ANTIVIRAL NUCLEOSIDES
#34Synthesis of 2′ protected nucleosides
#355'-O-Phenylacetyluridine and therapeutic use
#36PREPARATION METHOD OF 2'-SUBSTITUTED PYRIMIDINE NUCLEOSIDE
#372′,3′-Diacetyluridine Substituted With Acetoacetyl at the 5′ Position
#38DPAGT1 INHIBITORS OF CAPURAMYCIN ANALOGUES AND THEIR ANTIMIGRATORY ACTIVITIES OF SOLID TUMORS
#39Functionalized n-acetylgalactosamine analogs
#40BRIDGED NUCLEOSIDE AND NUCLEOTIDE
#41N4-Hydroxycytidine and Derivatives and Anti-Viral Uses Related Thereto
#42MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF
#43Pharmaceutical compositions and methods
#44Methods and Reagents for Synthesizing Nucleosides and Analogues Thereof
#45Functionalized n-acetylgalactosamine analogs
#46Ectonucleotidase inhibitors and methods of use thereof
#47URIDINE DIPHOSPHATE DERIVATIVES, PRODRUGS, COMPOSITIONS AND USES THEREOF
#48LIGAND-2'-MODIFIED NUCLEIC ACIDS, SYNTHESIS THEREOF AND INTERMEDIATE COMPOUNDS THEREOF
#49Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same
#50Pharmaceutical polymorphs of Molnupiravir
#51URIDINE NUCLEOSIDE DERIVATIVES, COMPOSITIONS AND METHODS OF USE
#52PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#53NOVEL PHOSPHORAMIDITES
#54N4-hydroxycytidine and derivatives and anti-viral uses related thereto
#55Synthesis of modified oligonucleotides with increased stability
#56Methods of synthesizing substituted purine compounds
#57Methods of synthesizing substituted purine compounds
#58Artificial nucleoside and artificial nucleotide, and artificial oligonucleotide
#59COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#60Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#61N4-hydroxycytidine and derivatives and anti-viral uses related thereto
#62Nucleoside or nucleotide derivatives, and uses thereof
#63Autonomous device for measuring the characteristics of a fluid circulating in a conduit and system for controlling ventilation, air conditioning and/or heating using such a device
#64MODIFIED OLIGONUCLEOTIDES AND METHODS FOR THEIR SYNTHESIS
#65Uridine nucleoside derivatives, compositions and methods of use
#665′ modified nucleosides and oligomeric compounds prepared therefrom
#67Method for synthesizing ribonucleic acid H-phosphonate monomer, and oligonucleotide synthesis in which said monomer is used
#68Method for improving the oral bioavailability of a drug
#69N4-hydroxycytidine and derivatives and anti-viral uses related thereto
#70Catalyst-free and redox-neutral innate trifluoromethylation and alkylation of (hetero)aromatics enabled by light
#71Tunicamycin analogues
#72Pharmaceutical compositions and methods
#73Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof
#74Ectonucleotidase inhibitors and methods of use thereof
#75Methods of synthesizing substituted purine compounds
#76Compositions and methods for the treatment of cancer
#77ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
#78Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
#79Method for liquid-phase synthesis of nucleic acid
#80Pharmaceutical compositions and methods
#81Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same
#82N4-hydroxycytidine and derivatives and anti-viral uses related thereto
#83N4-Hydroxycytidine and Derivatives and Anti-Viral Uses Related Thereto
#84Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#85Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same
#86Linkage modified oligomeric compounds
#87Oligonucleotide production method, and nucleoside, nucleotide, or oligonucleotide
#88Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#89Protected monomer and method of final deprotection for RNA synthesis
#90Pharmaceutical compositions and methods
#91METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS
#92METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS
#93Method for producing glycoside compounds
#94Modified oligonucleotides and methods for their synthesis
#95Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
#96Alternative nucleic acid molecules and uses thereof
#97Monomers and oligonucleotides comprising cycloaddition adduct(s)
#98Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof
#992′/3′/5′-(R/S)-serinyl functionalized oligonucleotides
#100Linkage modified oligomeric compounds
#101Dithiolane functionalized nucleoside amidites and supports for stronger immobilization of bio-molecules on solid surfaces
#102C1-phostphonate analogue of UDP-GlcNAc for inhibition of O-GlcNAc transferase
#103Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same
#104Substituted gemcitabine aryl amide analogs
#105RNA monomers containing 0-acetal levulinyl ester groups and their use in RNA microarrays
#106Methods of synthesizing substituted purine compounds
#1074′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication
#108Uridine diphosphate derivatives, prodrugs, compositions and methods for treating neurodegenerative disorders
#109Polynucleotide molecules and uses thereof
#110Mutual prodrug comprising short chain fatty acids and zebularine or 1'-cyano-cytarabine for cancer treatment
#111Synthesis of four-color 3′-O-allyl modified photocleavable fluorescent nucleotides and related methods
#112Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#113Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid
#114Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient
#115Combined anti-acid-fast bacterial agent, screening method for anti-acid-fast bacterial agents, and activity inhibitor of WecA or ortholog thereof
#116Monomers and oligonucleotides comprising cycloaddition adduct(s)
#1175′ modified nucleosides and oligomeric compounds prepared therefrom
#118Methods of synthesizing substituted purine compounds
#119Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl) cytosine, synthetic intermediate of thionucleoside, and method for producing the same
#120Cell-penetrating oligonucleotides
#121Protected monomer and method of final deprotection for RNA synthesis
#122Method for liquid-phase synthesis of nucleic acid
#1232′-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#124Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#125Substituted gemcitabine aryl amide analogs
#126Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites and oligonucleotides
#127Prodrugs for selective anticancer therapy
#128RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end
#129Azido nucleosides and nucleotide analogs
#130Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#131Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same
#132Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof
#133Uridine nucleoside derivatives, compositions and methods of use
#1341′,4′-thio nucleosides for the treatment of HCV
#135IDO inhibitors
#136Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient
#137Highly active nucleoside derivative for the treatment of HCV
#138Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer
#139Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid
#140Methods for treating glaucoma using uridine diphosphate derivatives
#141Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
#142Synthesis of deuterated ribo nucleosides N-protected phosphoramidites, and oligonucleotides
#143Uridine-based gadolinium complex and MRI contrast agent including the same
#1445′-end derivatives
#1452'-O-modified RNA
#146Method of isolating purified RNA with reduced DNA contaminations
#147Uracyl spirooxetane nucleosides
#1482′ and 5′ modified monomers and oligonucleotides
#1495′ modified nucleosides and oligomeric compounds prepared therefrom
#150Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#151RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end
#152Monomers and oligonucleotides comprising cycloaddition adduct(s)
#153Protected monomer and method of final deprotection for RNA synthesis
#1541′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
#155PROTECTED MONOMERS AND METHODS OF DEPROTECTION FOR RNA SYNTHESIS
#156RADIOLABELED NUCLEOSIDE ANALOGUE, AND PREPARATION METHOD AND USE THEREOF
#157RNA monomers containing O-acetal levulinyl ester groups and their use in RNA microarrays
#158Synthesis of four-color 3′-O-allyl modified photocleavable fluorescent nucleotides and related methods
#159Azido nucleosides and nucleotide analogs
#160SUBSTITUTED NUCLEOTIDE ANALOGS
#161Uracyl spirooxetane nucleosides
#162Amphiphile prodrugs
#163Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference
#164Modified nucleotides
#165Method for preparing oligonucleotide
#166Anti-XDR-TB drug, anti-MDR-TB drug, and combination anti-tuberculosis drug
#167LOCKED AND UNLOCKED 2'-O PHOSPHORAMIDITE NUCLEOSIDES, PROCESS OF PREPARATION THEREOF AND OLIGOMERS COMPRISING THE NUCLEOSIDES
#168Nucleoside triphosphate derivative, nucleic acid probe, multilabeled nucleic acid probe, method for production of multilabeled nucleic acid probe, and method for detection of target nucleic acid
#169Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
#170Protective group for synthesis of RNA and derivative
#171Antiviral nucleosides
#172Compositions and methods for treatment of mitochondrial diseases
#173Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA
#174IDO inhibitors
#175Production process of ethynylthymidine compounds from 5-methyluridine as a starting material
#176DEUTERIUM-ENRICHED CAPECITABINE
#177Process for Producing Fluorocytidine Derivatives
#1782′-hydroxy-protected ribonucleoside derivative and production method thereof
#179RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end
#180Set of Geldanamycin Derivatives and Their Preparation Methods
#181PROCESS FOR PRODUCTION OF RIBOFURANOSE DERIVATIVES
#182Mutagenic Nucleoside Analogs for the Treatment of Viral Disease
#183Preparation of nucleotide oligomer
#184SUBSTITUTED NUCLEOSIDE AND NUCLEOTIDE ANALOGS
#185PROCESS FOR PREPARING CAPECITABINE
#186Cytidine derivative-containing antitumor agent for continuous intravenous administration
#187Fluorous Oligonucleotide Reagents and Affinity Purification of Oligonucleotides
#188ODCASE INHIBITORS AS ANTI-VIRALS AND ANTIBIOTICS
#189PROTECTED MONOMER AND METHOD OF FINAL DEPROTECTION FOR RNA SYNTHESIS
#190THIONUCLEOSIDES AND PHARMACEUTICAL APPLICATIONS
#191Pyrimidine Derivatives As Anticancer Agents
#192Synthesis of four color 3′O-allyl, modified photocleavable fluorescent nucleotides and related methods
#1932′-hydroxyl group-modified ribonucleoside derivatives
#194METHOD FOR REMOVAL OF NUCLEIC ACID-PROTECTING GROUP
#195Therapeutic agent for neurodegenerative disease
#196ODCase inhibitors for the treatment of malaria
#197Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof
#198Agent against psychosocial stresses
#199Deuterium-enriched capecitabine
#200PREPARATION OF GEMCITABINE
#201Nucleoside based proliferation imaging markers
#202Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides
#203Process for the preparation of 4′-azido cytidine derivatives
#204Artificial RNAóS modified at the 2ó-hydroxyl group
#205Phosphoramidite compound and method for producing oligo-RNA
#206Detectable labeled nucleoside analogs and methods of use thereof
#207Detectable labeled nucleoside analogs and methods of use thereof
#208Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound
#209Selective O-acylation of nucleosides
#2102' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#2112' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#2122' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#2132' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#2142′ and 3′-nucleoside prodrugs for treating infections
#2152' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#2162' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#217Sugar modified nucleosides as viral replication inhibitors
#2182′ and 3′-nucleoside prodrugs for treating infections
#219Compositions and methods for treatment of mitochondrial diseases
#220Processing for producing 2′-deoxy-2′-fluorouridine
#221Fluorous oligonucleotide reagents and affinity purification of oligonucleotides
#222Caprazene as novel compound and derivatives thereof, and caprazol as novel compound and derivatives thereof
#2234'-thionucleotide
#224Anti-viral nucleosides
#225Method for deuteration of a heterocyclic ring
#226Processes for production of nucleosides
#227Compositions and methods for treatment of mitochondrial diseases
#228Metallic salt of N4-acylcytidine derivatives, and a method for producing N4-acylcytidine derivatives using the same
#229Process for producing N-Acyl-5′-deoxy-5-fluorocytidine
#230Method for producing a pyrimidine nucleoside compound and a new pyrimidine nucleoside compound
#231Nucleotide derivative and DNA microarray
#232Processes for preparing 4'-azido-nucleoside derivatives
#233Process for molnupiravir